1,820
Views
72
CrossRef citations to date
0
Altmetric
Original Research

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma

, , , , , , , & show all
Article: e1387706 | Received 16 Jun 2017, Accepted 29 Sep 2017, Published online: 06 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jennifer Crow, Glenson Samuel & Andrew K. Godwin. (2019) Beyond tumor mutational burden: potential and limitations in using exosomes to predict response to immunotherapy. Expert Review of Molecular Diagnostics 19:12, pages 1079-1088.
Read now
Ernest Y. Lee & Rajan P. Kulkarni. (2019) Circulating biomarkers predictive of tumor response to cancer immunotherapy. Expert Review of Molecular Diagnostics 19:10, pages 895-904.
Read now

Articles from other publishers (69)

Jinghan Yang, Liang Qiu, Xi Wang, Xi Chen, Pingdong Cao, Zhe Yang & Qiang Wen. (2023) Liquid biopsy biomarkers to guide immunotherapy in breast cancer. Frontiers in Immunology 14.
Crossref
Karama Asleh, Valerie Dery, Catherine Taylor, Michelle Davey, Marie-Ange Djeungoue-Petga & Rodney J. Ouellette. (2023) Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology. Biomarker Research 11:1.
Crossref
Lotte L. Hoeijmakers, Irene L.M. Reijers & Christian U. Blank. (2023) Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma. Cancer Discovery 13:11, pages 2319-2338.
Crossref
Yanjun Wang, Shuo Yang, Li Wan, Wei Ling, Hao Chen & Jinghua Wang. (2023) New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review). International Journal of Oncology 63:1.
Crossref
Youliang Zhao, Yaqian Qu, Changfu Hao & Wu Yao. (2023) PD-1/PD-L1 axis in organ fibrosis. Frontiers in Immunology 14.
Crossref
Joshua Johnson, So‐Youn Kim, Peter Ka Sam, Rengasamy Asokan, Evelyn Llerena Cari, Elise S. Bales, Thanh‐Ha Luu, Lauren Perez, Amanda N. Kallen, Liesl Nel‐Themaat, Alex J. Polotsky, Miriam D. Post, David J. Orlicky, Kimberly R. Jordan & Benjamin G. Bitler. (2022) Expression and T cell regulatory action of the PD‐1 immune checkpoint in the ovary and fallopian tube. American Journal of Reproductive Immunology 89:3.
Crossref
Alice Musi & Laura Bongiovanni. (2023) Extracellular Vesicles in Cancer Drug Resistance: Implications on Melanoma Therapy. Cancers 15:4, pages 1074.
Crossref
Lidia B. Medhin, Aaron B. Beasley, Lydia Warburton, Benhur Amanuel & Elin S. Gray. (2023) Extracellular vesicles as a liquid biopsy for melanoma: Are we there yet?. Seminars in Cancer Biology 89, pages 92-98.
Crossref
Achmad Himawan, Lalitkumar K. Vora, Andi Dian Permana, Sumarheni Sudir, Airin R. Nurdin, Ririn Nislawati, Rafikah Hasyim, Christopher J. Scott & Ryan F. Donnelly. (2022) Where Microneedle Meets Biomarkers: Futuristic Application for Diagnosing and Monitoring Localized External Organ Diseases. Advanced Healthcare Materials 12:5, pages 2202066.
Crossref
James W. ClancyCrislyn D'Souza-Schorey. (2023) Tumor-Derived Extracellular Vesicles: Multifunctional Entities in the Tumor Microenvironment. Annual Review of Pathology: Mechanisms of Disease 18:1, pages 205-229.
Crossref
Fan Yang, Chloe Shay, Marin Abousaud, Chris Tang, Yamin Li, Zhaohui Qin, Nabil F. Saba & Yong Teng. (2023) Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Seyedeh Alia Moosavian, Maryam Hashemi, Leila Etemad, Sara Daneshmand & Zahra Salmasi. (2022) Melanoma-derived exosomes: Versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma. International Immunopharmacology 113, pages 109320.
Crossref
Keywan Mortezaee & Jamal Majidpoor. (2022) Extracellular vesicle-based checkpoint regulation and immune state in cancer. Medical Oncology 39:12.
Crossref
Radhika Manukonda, Vengala Rao Yenuganti, Nupur Nagar, Pankaj Singh Dholaniya, Shivani Malpotra, Jyothi Attem, Mamatha M. Reddy, Saumya Jakati, Dilip K Mishra, Pallu Reddanna, Krishna Mohan Poluri, Geeta K. Vemuganti & Swathi Kaliki. (2022) Comprehensive Analysis of Serum Small Extracellular Vesicles-Derived Coding and Non-Coding RNAs from Retinoblastoma Patients for Identifying Regulatory Interactions. Cancers 14:17, pages 4179.
Crossref
Radhika Manukonda, Jyothi Attem, Vengala Rao Yenuganti, Swathi Kaliki & Geeta K. Vemuganti. (2022) Exosomes in the visual system: New avenues in ocular diseases. Tumor Biology 44:1, pages 129-152.
Crossref
Ya Liu, Gang Yu, Yan-Yan Ding & Yong-Xia Zhang. (2022) Expression of miR-155 in Serum Exosomes in Children with Epilepsy and Its Diagnostic Value. Disease Markers 2022, pages 1-6.
Crossref
Li Zhao, Sara Corvigno, Shaolin Ma, Joseph Celestino, Nicole D. Fleming, Richard A. Hajek, Adrian Lankenau Ahumada, Nicholas B. Jennings, Erika J. Thompson, Hongli Tang, Shannon N. Westin, Amir A. Jazaeri, Jianhua Zhang, P. Andrew Futreal, Anil K. Sood & Sanghoon Lee. (2022) Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer. Cancers 14:15, pages 3589.
Crossref
Yufang Tan, Fang Tang, Jieming Li, Honghao Yu, Min Wu, Yiping Wu, Hong Zeng, Kai Hou & Qi Zhang. (2022) Tumor-derived exosomes: the emerging orchestrators in melanoma. Biomedicine & Pharmacotherapy 149, pages 112832.
Crossref
Saife N. Lone, Sabah Nisar, Tariq Masoodi, Mayank Singh, Arshi Rizwan, Sheema Hashem, Wael El-Rifai, Davide Bedognetti, Surinder K. Batra, Mohammad Haris, Ajaz A. Bhat & Muzafar A. Macha. (2022) Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Molecular Cancer 21:1.
Crossref
Fenglong Bie, He Tian, Nan Sun, Ruochuan Zang, Moyan Zhang, Peng Song, Lei Liu, Yue Peng, Guangyu Bai, Bolun Zhou & Shugeng Gao. (2022) Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC. Frontiers in Oncology 12.
Crossref
Mohsen Karami Fath, Ali Azargoonjahromi, Nafiseh Jafari, Maryam Mehdi, Fatemeh Alavi, Mona Daraei, Niloufar Mohammadkhani, Anna-Lena Mueller, Aranka Brockmueller, Mehdi Shakibaei & Zahra Payandeh. (2022) Exosome application in tumorigenesis: diagnosis and treatment of melanoma. Medical Oncology 39:2.
Crossref
Keywan Mortezaee, Jamal Majidpoor & Fardin Fathi. (2022) Extracellular vesicle isolation, purification and evaluation in cancer diagnosis. Expert Reviews in Molecular Medicine 24.
Crossref
Chang Liu, Miao Wang, Changli Xu, Bo Li, Juxiang Chen, Jianchun Chen & Zhiwei Wang. (2021) Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation. Journal of Immunology Research 2021, pages 1-18.
Crossref
Simona Lobasso, Paola Tanzarella, Francesco Mannavola, Marco Tucci, Francesco Silvestris, Claudia Felici, Chiara Ingrosso, Angela Corcelli & Patrizia Lopalco. (2021) A Lipidomic Approach to Identify Potential Biomarkers in Exosomes From Melanoma Cells With Different Metastatic Potential. Frontiers in Physiology 12.
Crossref
Filipa D. Oliveira, Miguel A. R. B. Castanho & Vera Neves. (2021) Exosomes and Brain Metastases: A Review on Their Role and Potential Applications. International Journal of Molecular Sciences 22:19, pages 10899.
Crossref
Paula Kamińska, Karolina Buszka, Maciej Zabel, Michał Nowicki, Catherine Alix-Panabières & Joanna Budna-Tukan. (2021) Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring. International Journal of Molecular Sciences 22:18, pages 9714.
Crossref
Qiu Peng & Jia Wang. (2021) Non-coding RNAs in melanoma: Biological functions and potential clinical applications. Molecular Therapy - Oncolytics 22, pages 219-231.
Crossref
Ho Jung An, Hong Jae Chon & Chan Kim. (2021) Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors. International Journal of Molecular Sciences 22:17, pages 9414.
Crossref
Panagiota Maravelia, Daniela Nascimento Silva, Giulia Rovesti, Michael Chrobok, Per Stål, Yong-Chen Lu & Anna Pasetto. (2021) Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy. Cancers 13:17, pages 4334.
Crossref
Gabriele Madonna, Giuseppe V. Masucci, Mariaelena Capone, Domenico Mallardo, Antonio Maria Grimaldi, Ester Simeone, Vito Vanella, Lucia Festino, Marco Palla, Luigi Scarpato, Marilena Tuffanelli, Grazia D'angelo, Lisa Villabona, Isabelle Krakowski, Hanna Eriksson, Felipe Simao, Rolf Lewensohn & Paolo Antonio Ascierto. (2021) Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy. Cancers 13:16, pages 4164.
Crossref
Yufan Qiu, Yi Yang, Riyao Yang, Chunxiao Liu, Jung-Mao Hsu, Zhou Jiang, Linlin Sun, Yongkun Wei, Chia-Wei Li, Dihua Yu, Jin Zhang & Mien-Chie Hung. (2021) Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer. Oncogene 40:31, pages 4992-5001.
Crossref
Xi-Yang Tang, An-Ping Shi, Yan-Lu Xiong, Kai-Fu Zheng, Yu-Jian Liu, Xian-Gui Shi, Tao Jiang & Jin-Bo Zhao. (2021) Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis. Frontiers in Oncology 11.
Crossref
Lanlan Chen, Shenhui Huang, Jincheng Huang, Qiujuan Chen & Qihong Zhuang. (2021) Role and Mechanism of Exosome-Derived Long Noncoding RNA HOTAIR in Lung Cancer. ACS Omega 6:27, pages 17217-17227.
Crossref
Benhui Liang, Ximin Hu, Yinghe Ding & Mujun Liu. (2020) Tumor‐derived exosomes in the PD‐1/PD‐L1 axis: Significant regulators as well as promising clinical targets. Journal of Cellular Physiology 236:6, pages 4138-4151.
Crossref
E Zhou, Yumei Li, Feng Wu, Mengfei Guo, Juanjuan Xu, Sufei Wang, Qi Tan, Pei Ma, Siwei Song & Yang Jin. (2021) Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy. EBioMedicine 67, pages 103365.
Crossref
Mattia Garutti, Serena Bonin, Silvia Buriolla, Elisa Bertoli, Maria Antonietta Pizzichetta, Iris Zalaudek & Fabio Puglisi. (2021) Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma. Cancers 13:8, pages 1819.
Crossref
Xianghu Jiang, Guohong Liu, Yirong Li & Yunbao Pan. (2021) Immune checkpoint: The novel target for antitumor therapy. Genes & Diseases 8:1, pages 25-37.
Crossref
Mitchell P. Levesque. 2021. Systems Medicine. Systems Medicine 361 364 .
Stephanie M. Bollard, Cristina Casalou, Chia Yin Goh, Desmond J. Tobin, Pamela Kelly, Amanda McCann & Shirley M. Potter. (2020) Circulating Melanoma-Derived Extracellular Vesicles: Impact on Melanoma Diagnosis, Progression Monitoring, and Treatment Response. Pharmaceuticals 13:12, pages 475.
Crossref
Anna Passarelli, Giovanna Galdo, Michele Aieta, Tommaso Fabrizio, Antonio Villonio & Raffaele Conca. (2020) A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the Literature. International Journal of Molecular Sciences 21:22, pages 8596.
Crossref
Marco Antônio Marques Pretti, Sara Santos Bernardes, Jéssica Gonçalves Vieira da Cruz, Mariana Boroni & Patrícia A Possik. (2020) Extracellular vesicle-mediated crosstalk between melanoma and the immune system: Impact on tumor progression and therapy response. Journal of Leukocyte Biology 108:4, pages 1101-1115.
Crossref
Valeria Internò, Marco Tucci, Gaetano Pezzicoli, Franco Silvestris, Camillo Porta & Francesco Mannavola. (2020) Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer. Frontiers in Oncology 10.
Crossref
Gaetano Pezzicoli, Marco Tucci, Domenica Lovero, Franco Silvestris, Camillo Porta & Francesco Mannavola. (2020) Large Extracellular Vesicles—A New Frontier of Liquid Biopsy in Oncology. International Journal of Molecular Sciences 21:18, pages 6543.
Crossref
Mauro Cives, Francesco Mannavola, Lucia Lospalluti, Maria Chiara Sergi, Gerardo Cazzato, Elisabetta Filoni, Federica Cavallo, Giuseppe Giudice, Luigia Stefania Stucci, Camillo Porta & Marco Tucci. (2020) Non-Melanoma Skin Cancers: Biological and Clinical Features. International Journal of Molecular Sciences 21:15, pages 5394.
Crossref
Matthew C. Knox, Jie Ni, Andrej Bece, Joseph Bucci, Yaw Chin, Peter H. Graham & Yong Li. (2020) A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications. Frontiers in Immunology 11.
Crossref
Patricia M. LoRusso, Kurt Schalper & Jeffrey Sosman. (2020) Targeted therapy and immunotherapy: Emerging biomarkers in metastatic melanoma. Pigment Cell & Melanoma Research 33:3, pages 390-402.
Crossref
Kenji Chamoto, Ryusuke Hatae & Tasuku Honjo. (2020) Current issues and perspectives in PD-1 blockade cancer immunotherapy. International Journal of Clinical Oncology 25:5, pages 790-800.
Crossref
Francesco Mannavola, Gaetano Pezzicoli & Marco Tucci. (2020) DLC-1 down-regulation via exosomal miR-106b-3p exchange promotes CRC metastasis by the epithelial-to-mesenchymal transition. Clinical Science 134:8, pages 955-959.
Crossref
Corinna Keup, Rainer Kimmig & Sabine Kasimir-Bauer. (2020) Liquid Biopsies to Evaluate Immunogenicity of Gynecological/Breast Tumors: On the Way to Blood-Based Biomarkers for Immunotherapies. Breast Care 15:5, pages 470-480.
Crossref
Qianqian Hou & Heng Xu. 2020. Regulation of Cancer Immune Checkpoints. Regulation of Cancer Immune Checkpoints 143 166 .
Francesco Mannavola, Stella D’Oronzo, Mauro Cives, Luigia Stefania Stucci, Girolamo Ranieri, Franco Silvestris & Marco Tucci. (2019) Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression. International Journal of Molecular Sciences 21:1, pages 52.
Crossref
Francesco Mannavola, Marco Tucci, Claudia Felici, Anna Passarelli, Stella D’Oronzo & Francesco Silvestris. (2019) Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. Journal of Translational Medicine 17:1.
Crossref
Joshua L. Hood. (2019) Natural melanoma-derived extracellular vesicles. Seminars in Cancer Biology 59, pages 251-265.
Crossref
Marco Tucci, Anna Passarelli, Francesco Mannavola, Claudia Felici, Luigia Stefania Stucci, Mauro Cives & Francesco Silvestris. (2019) Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. Frontiers in Oncology 9.
Crossref
Muhammad Babar Khawar, Muddasir Hassan Abbasi, Zerwa Siddique, Amin Arif & Nadeem Sheikh. (2019) An Update on Novel Therapeutic Warfronts of Extracellular Vesicles (EVs) in Cancer Treatment: Where We Are Standing Right Now and Where to Go in the Future. Oxidative Medicine and Cellular Longevity 2019, pages 1-21.
Crossref
Francesco Mannavola, Tina Salerno, Anna Passarelli, Marco Tucci, Valeria Internò & Francesco Silvestris. (2019) Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now?. Frontiers in Oncology 9.
Crossref
Yoshiyuki Nakamura. (2019) Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events. Frontiers in Medicine 6.
Crossref
Inbal Wortzel, Shani Dror, Candia M. Kenific & David Lyden. (2019) Exosome-Mediated Metastasis: Communication from a Distance. Developmental Cell 49:3, pages 347-360.
Crossref
Anna Passarelli, Marco Tucci, Francesco Mannavola, Claudia Felici & Francesco Silvestris. (2019) The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine. Tumor Biology 41:4, pages 101042831983713.
Crossref
Yun TengHui KangYang Chu. (2019) Identification of an Exosomal Long Noncoding RNA SOX2-OT in Plasma as a Promising Biomarker for Lung Squamous Cell Carcinoma. Genetic Testing and Molecular Biomarkers 23:4, pages 235-240.
Crossref
Anna Gajos-Michniewicz & Malgorzata Czyz. (2019) Role of miRNAs in Melanoma Metastasis. Cancers 11:3, pages 326.
Crossref
Wen‐Ming Wang, Chao Wu & Hong‐Zhong Jin. (2019) Exosomes in chronic inflammatory skin diseases and skin tumors. Experimental Dermatology 28:3, pages 213-218.
Crossref
Jonathan J. Havel, Diego Chowell & Timothy A. Chan. (2019) The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nature Reviews Cancer 19:3, pages 133-150.
Crossref
Alvaro Moreira, Stefanie Gross, Michael Constantin Kirchberger, Michael Erdmann, Gerold Schuler & Lucie Heinzerling. (2018) Senescence markers: Predictive for response to checkpoint inhibitors. International Journal of Cancer 144:5, pages 1147-1150.
Crossref
Marco Tucci, Anna Passarelli, Annalisa Todisco, Francesco Mannavola, Luigia Stefania Stucci, Stella D’Oronzo, Michele Rossini, Marco Taurisano, Loreto Gesualdo & Franco Silvestris. (2019) The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. Therapeutic Advances in Medical Oncology 11, pages 175883591987554.
Crossref
Xi Li, Yanan Wang, Qi Wang, Yinping Liu, Wei Bao & Sufang Wu. (2018) Exosomes in cancer: Small transporters with big functions. Cancer Letters 435, pages 55-65.
Crossref
Jian Lu, Jing Wu, Jie Tian & Shengjun Wang. (2018) Role of T cell-derived exosomes in immunoregulation. Immunologic Research 66:3, pages 313-322.
Crossref
Sophie Mumford, Benjamin Towler, Amy Pashler, Onur Gilleard, Yella Martin & Sarah Newbury. (2018) Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine. Biomolecules 8:2, pages 21.
Crossref
Raffaele Palmirotta, Domenica Lovero, Paola Cafforio, Claudia Felici, Francesco Mannavola, Eleonora Pellè, Davide Quaresmini, Marco Tucci & Franco Silvestris. (2018) Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Therapeutic Advances in Medical Oncology 10, pages 175883591879463.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.